Literature DB >> 20960436

Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

Estelle Dellapina1, Angélique Gerdelat-Mas, Fabienne Ory-Magne, Laure Pourcel, Monique Galitzky, Fabienne Calvas, Marion Simonetta-Moreau, Claire Thalamas, Pierre Payoux, Christine Brefel-Courbon.   

Abstract

Patients with Parkinson's disease (PD) frequently experience pain that could be in part due to central modification of nociception. In this randomized controlled double blind study, we compared the effect of apomorphine versus placebo on pain thresholds and pain-induced cerebral activity in 25 patients with PD. Subjective pain threshold (using thermal stimulation, thermotest), objective pain threshold (nociceptive flexion reflex), and cerebral activity (H(2)(15)O PET) during noxious and innocuous stimulations were performed. Neither subjective nor objective pain thresholds nor pain activation profile were modified by apomorphine compared with placebo in 25 PD patients. Apomorphine has no effect on pain processing in PD. We suggest that other monoamine systems than dopaminergic system could be involved.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960436     DOI: 10.1002/mds.23406

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

3.  Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease.

Authors:  Alessandro Tessitore; Antonio Russo; Rosa De Micco; Michele Fratello; Giuseppina Caiazzo; Alfonso Giordano; Mario Cirillo; Gioacchino Tedeschi; Fabrizio Esposito
Journal:  Hum Brain Mapp       Date:  2017-11-15       Impact factor: 5.038

Review 4.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 5.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 6.  Pains in Parkinson disease--many syndromes under one umbrella.

Authors:  Gunnar Wasner; Günther Deuschl
Journal:  Nat Rev Neurol       Date:  2012-04-17       Impact factor: 42.937

Review 7.  Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Authors:  Eva Schaeffer; Daniela Berg
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

Review 8.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

Review 9.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 10.  Pain in Parkinson's disease and the role of the subthalamic nucleus.

Authors:  Abteen Mostofi; Francesca Morgante; Mark J Edwards; Peter Brown; Erlick A C Pereira
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.